Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal) (TA960)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2024
Phrenic nerve pacing for congenital central hypoventilation syndromeStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 21 August 2024
Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injuryStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 21 August 2024
Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 4 December 2024
Robot-assisted surgery for orthopaedic procedures: early value assessmentStatus:In developmentProgramme:Health technology evaluationExpected publication date: 21 January 2025
Spinal instrumentation with robot assisted navigationStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Inebilizumab for treating AQP4-IgG seropositive neuromyelitis optica spectrum disorders ID6430Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
HealthVCF for detecting vertebral compression fractures on CT scans MT581 (MIB267)Status:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC